IM CANNABIS CORP (IMCC) Stock Price, Forecast & Analysis

USA Nasdaq NASDAQ:IMCC • CA44969Q4060

1.19 USD
-0.02 (-1.65%)
At close: Feb 4, 2026
1.15 USD
-0.04 (-3.36%)
After Hours: 2/4/2026, 8:28:16 PM

IMCC Key Statistics, Chart & Performance

Key Statistics
Market Cap6.25M
Revenue(TTM)54.03M
Net Income(TTM)-4.69M
Shares5.25M
Float2.90M
52 Week High7.12
52 Week Low0.93
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-2.48
PEN/A
Fwd PEN/A
Earnings (Next)03-30
IPO2019-11-05
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
IMCC short term performance overview.The bars show the price performance of IMCC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

IMCC long term performance overview.The bars show the price performance of IMCC in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of IMCC is 1.19 USD. In the past month the price decreased by -19.05%. In the past year, price decreased by -49.8%.

IM CANNABIS CORP / IMCC Daily stock chart

IMCC Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

IMCC Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to IMCC. Both the profitability and financial health of IMCC have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IMCC Financial Highlights

Over the last trailing twelve months IMCC reported a non-GAAP Earnings per Share(EPS) of -2.48. The EPS increased by 11.98% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -10.43%
ROE -88.04%
Debt/Equity 2.52
Chartmill High Growth Momentum
EPS Q2Q%58.09%
Sales Q2Q%-14.29%
EPS 1Y (TTM)11.98%
Revenue 1Y (TTM)10.71%

IMCC Forecast & Estimates

For the next year, analysts expect an EPS growth of 86.24% and a revenue growth 41.23% for IMCC


Analysts
Analysts82.86
Price TargetN/A
EPS Next Y86.24%
Revenue Next Year41.23%

IMCC Ownership

Ownership
Inst Owners18.37%
Ins Owners41.71%
Short Float %2.11%
Short Ratio0.34

IMCC Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
LLY ELI LILLY & CO32.981.047T
JNJ JOHNSON & JOHNSON20.28564.909B
MRK MERCK & CO. INC.21.87293.697B
PFE PFIZER INC8.92152.263B
BMY BRISTOL-MYERS SQUIBB CO9.49117.3B
ZTS ZOETIS INC18.4955.835B
RPRX ROYALTY PHARMA PLC- CL A8.4225.214B
VTRS VIATRIS INC5.6916.539B
ELAN ELANCO ANIMAL HEALTH INC23.1412.123B
AXSM AXSOME THERAPEUTICS INC227.149.353B

About IMCC

Company Profile

IMCC logo image IM Cannabis Corp. engages in the production and sale of medical cannabis products. The company employs 55 full-time employees The company went IPO on 2019-11-05. The firm's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The firm's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.

Company Info

IM CANNABIS CORP

Kibbutz Glil Yam

TORONTO ONTARIO IL

CEO: Oren Shuster

Employees: 55

IMCC Company Website

IMCC Investor Relations

Phone: 14162564202

IM CANNABIS CORP / IMCC FAQ

What does IMCC do?

IM Cannabis Corp. engages in the production and sale of medical cannabis products. The company employs 55 full-time employees The company went IPO on 2019-11-05. The firm's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The firm's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.


Can you provide the latest stock price for IM CANNABIS CORP?

The current stock price of IMCC is 1.19 USD. The price decreased by -1.65% in the last trading session.


What is the dividend status of IM CANNABIS CORP?

IMCC does not pay a dividend.


What is the ChartMill technical and fundamental rating of IMCC stock?

IMCC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the market capitalization of IMCC stock?

IM CANNABIS CORP (IMCC) has a market capitalization of 6.25M USD. This makes IMCC a Nano Cap stock.


Can you provide the ownership details for IMCC stock?

You can find the ownership structure of IM CANNABIS CORP (IMCC) on the Ownership tab.